A near-infrared AIE probe targeting COX-2 for imaging of Cancer cells
Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy · 2026
DOI: 10.1016/j.saa.2025.126696 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 2026. Verfasst von Jianxi Liu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Key Laboratory of Molecular Pharmacol…. Hauptthemen laut MEDLINE: Cyclooxygenase 2, Neoplasms, Fluorescent Dyes. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: Shandong Province Natural Science Foundation.
Abstract (Originalsprache)
High expression of cyclooxygenase-2 (COX-2) in the inflammatory tumor microenvironment is a critical target for early cancer diagnosis. We designed and synthesized a series of near-infrared (NIR) fluorescent probes based on the aggregation-induced emission (AIE) mechanism for targeted COX-2 imaging. Leveraging a D-π-A quinoline-malononitrile core, we developed probes YL-180 (non-targeted control), YL-181 (celecoxib conjugate), and YL-186 (indomethacin conjugate). Notably, this work represents the first report combining this specific AIE core with established COX-2 targeting ligands, celecoxib and indomethacin, for this application. These probes exhibit characteristic AIE properties, with YL-181 showing fluorescence enhancement up to approximately 9.7-fold from pure THF in aggregated state, effectively overcoming the aggregation-caused quenching (ACQ) issue. They also possess favorable optical features including NIR emission (>650 nm) and large Stokes shifts (>200 nm). Their aggregation behavior and nanoparticle formation were characterized by DLS and TEM. In vitro cellular imaging revealed that YL-181 achieved superior tumor cell selectivity, demonstrating approximately 22-fold higher fluorescence intensity in MCF-7 cancer cells over normal HUVEC cells (around 4-fold for YL-186 over normal HUVEC cells). A competitive assay confirmed YL-181's specific COX-2 binding. Furthermore, YL-181 sensitively reflected intracellular COX-2 levels, with fluorescence decreasing by approximately 97 % from untreated upon COX-2 inhibition and increasing by around 135 % from untreated upon induction. Molecular docking and dynamics simulations provided insights into the specific binding mode and dynamic stability of YL-181 with COX-2 from an atomic perspective. In vivo imaging validated YL-181's excellent tumor targeting ability and high contrast performance in mouse models, showing a tumor-to-background ratio (TBR) of around 1.83 from normal tissue background, consistent with ex vivo organ analysis. Our highly sensitive and selective COX-2 targeted AIE probe, YL-181, holds significant potential for precise early tumor imaging.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Key Laboratory of Molecular Pharmacology and Drug Evaluation, Ministry of Education, School of Pharmacy, Ya…
- State Key Laboratory of Advanced Drug Delivery and Release Systems, Shandong Luye Pharmaceutical Co., Ltd, Yantai, Shandong 264003, PR China.
Förderung
- Shandong Province Natural Science Foundation
Zitieren
APA
Liu, J., Zhang, Y., Hu, J., Chen, S., Xue, Y., Liu, W., Shen, L., Wang, A., Zhu, Y., & Xu, L. (2026). A near-infrared AIE probe targeting COX-2 for imaging of Cancer cells. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy. https://doi.org/10.1016/j.saa.2025.126696
Vancouver
Liu J, Zhang Y, Hu J, Chen S, Xue Y, Liu W, et al. A near-infrared AIE probe targeting COX-2 for imaging of Cancer cells. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy. 2026. doi:10.1016/j.saa.2025.126696
BibTeX
@article{Liu2026,
author = {Liu, Jianxi and Zhang, Yonglin and Hu, Jiale and Chen, Shulin and Xue, Ying and Liu, Wanhui and Shen, Li and Wang, Aiping and Zhu, Yanping and Xu, Lixiao},
title = {A near-infrared AIE probe targeting COX-2 for imaging of Cancer cells},
journal = {Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy},
year = {2026},
doi = {10.1016/j.saa.2025.126696}
}
EUVIMED